Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biofil Chemicals & Pharmaceuticals has submitted to the stock exchanges a routine compliance certificate from its Registrar and Share Transfer Agent (RTA), Ankit Consultancy Private Limited, for the quarter ended 30 June 2025. The certificate confirms under SEBI Regulation 74(5) that all dematerialization requests received from depository participants during the quarter were processed, the physical share certificates were mutilated and cancelled, and the register of members was updated with the depository as the registered owner within the required 15 days. The company (BSE Scrip Code: 524396, ISIN: INE829A01014) has no new financial or business announcement in this filing. The letter was signed by Apoorv Jain, Company Secretary & Compliance Officer, on 3 July 2025.
This is a routine procedural filing with no impact on financials, operations, or share price. It simply confirms the smooth functioning of share dematerialization processes for the quarter.